German Police Fire Water Cannon at Lockdown Protesters and Arrest Hundreds
German citizens protesting in Berlin on Nov. 18, 2020 against new more restrictive coronavirus lockdowns, masking and social distancing restrictions were dispersed by police forces using water cannons and pepper spray on the crowd of about 10,000. Whistling, chanting and banging saucepans while holding signs, most of the demonstrators were not wearing masks or social […]
Denmark Citizens Refuse Law Mandating Forced COVID-19 Vaccine
With a COVID-19 vaccine possibly rolling out to the public by December or early next year, some governments are pushing for a mandatory vaccine program, as in Denmark where it was met with protests. The national government in Denmark had to abandon a new law that would require a mandatory COVID-19 vaccine after Danish citizens took to the streets […]
Pfizer CEO Sold $5.6 Million Stock in Pre-Planned Sale on Day of Vaccine News Release
We are learning more about a stock sale by Pfizer CEO Albert Bourla on Monday, the same day the company announced its early vaccine trial results. We’ve seen certain circumstances like this before. That’s right… so remember, of course, Pfizer reported that 90 percent efficacy number on its vaccine trial on Monday. Its stock went […]
Pfizer’s Experimental COVID-19 Vaccine 90 Percent Effective?
The German biotech firm BioNTech SE issued a joint press release with its American partner Pfizer, Inc. on Nov. 9, 2020 to announce that interim analysis of a global Phase 3 study of their mRNA-based SARS-CoV-2 vaccine appeared to demonstrate an efficacy rate “above 90%”measured seven days after the second dose.1 “This is really a […]
Pfizer CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced
Story Highlights On Nov. 9, 2020, Pfizer released preliminary Phase 3 clinical trial data indicating that its experimental mRNA COVID-19 vaccine is 90 percent effective, triggering a big surge in stock price. Pfizer CEO Albert Bourla immediately sold 60 percent of his company stock, realizing a gain of $5.6 million in what the company called […]
Another Shot at a Vaccine for Lyme Disease
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]